David M. Kendall

Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Patients With Type 2 Diabetes Treated With Metformin and a Sulfonylurea

David M. Kendall, Matthew C. Riddle, Julio Rosenstock et al. · Diabetes Care · 2005 · 1.2K citations · Full text

Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study

Daniel J. Drucker, John B. Buse, Kristin Taylor et al. · The Lancet · 2008 · 1.1K citations

Non-pharmacological Intervention, Diabetes Management, Insulin Management +7

A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia

Ronald Goldberg, David M. Kendall, Mark A. Deeg et al. · Diabetes Care · 2005 · 795 citations · Full text

Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes

Lawrence Blonde, E. Klein, J. Han et al. · Diabetes Obesity and Metabolism · 2006 · 417 citations · Full text

Recommendations for Management of Diabetes During Ramadan

Monira Alarouj, Samir H. Assaad‐Khalil, John B. Buse et al. · Diabetes Care · 2010 · 402 citations · Full text

Fasting, Obesity, Metabolic Syndrome +16